Cabot (NYSE:CBT) Stock Rating Lowered by StockNews.com

StockNews.com cut shares of Cabot (NYSE:CBT - Free Report) from a buy rating to a hold rating in a research report released on Wednesday.

A number of other research firms have also recently commented on CBT. JPMorgan Chase & Co. lowered their price target on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. UBS Group lowered their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. Finally, Mizuho cut their price target on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, Cabot has a consensus rating of "Hold" and an average price target of $93.25.

Cabot Stock Performance

Shares of CBT stock traded up $2.25 during trading on Wednesday, hitting $79.60. The company's stock had a trading volume of 393,818 shares, compared to its average volume of 386,235. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The company has a market cap of $4.32 billion, a PE ratio of 10.57, a P/E/G ratio of 0.74 and a beta of 1.04. The business has a fifty day moving average of $83.53 and a 200-day moving average of $95.81. Cabot has a 52 week low of $73.63 and a 52 week high of $117.46.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, research analysts anticipate that Cabot will post 7.57 earnings per share for the current year.

Institutional Trading of Cabot

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Curat Global LLC purchased a new position in Cabot during the 1st quarter valued at about $83,000. NBC Securities Inc. increased its holdings in Cabot by 146,900.0% during the 1st quarter. NBC Securities Inc. now owns 2,940 shares of the specialty chemicals company's stock worth $244,000 after acquiring an additional 2,938 shares during the period. Rhumbline Advisers lifted its stake in Cabot by 4.2% in the 1st quarter. Rhumbline Advisers now owns 185,850 shares of the specialty chemicals company's stock worth $15,452,000 after purchasing an additional 7,419 shares in the last quarter. Delphi Management Inc. MA boosted its holdings in Cabot by 19.8% in the 1st quarter. Delphi Management Inc. MA now owns 16,627 shares of the specialty chemicals company's stock valued at $1,382,000 after purchasing an additional 2,749 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Cabot by 10,385.0% in the 1st quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company's stock valued at $11,751,000 after purchasing an additional 139,990 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.